Literature DB >> 30685842

Impaired Pentose Phosphate Pathway in the Spinal Cord of the hSOD1G93A Mouse Model of Amyotrophic Lateral Sclerosis.

Tesfaye Wolde Tefera1,2, Katherine Bartlett1, Shirley S Tran1, Mark P Hodson3,4,5, Karin Borges6.   

Abstract

Impairments in energy metabolism in amyotrophic lateral sclerosis (ALS) have long been known. However, the changes in the energy-producing pathways in ALS are not comprehensively understood. To investigate specific alterations in glucose metabolism in glycolytic, pentose phosphate, and TCA cycle pathways, we injected uniformly labeled [U-13C]glucose to wild-type and hSOD1G93A mice at symptom onset (80 days). Using liquid chromatography-tandem mass spectrometry (LC-MS/MS), levels of metabolites were determined in extracts of the cortex and spinal cord. In addition, the activities of several enzymes involved in glucose metabolism were quantified. In the spinal cord, the levels of pentose phosphate pathway (PPP) intermediate ribose 5-phosphate (p = 0.037) were reduced by 37% in hSOD1G93A mice, while the % 13C enrichments in glucose 6-phosphate were increased threefold. The maximal activities of the enzyme glucose 6-phosphate dehydrogenase were decreased by 24% in the spinal cord (p = 0.005), suggesting perturbations in the PPP. The total amount of pyruvate in the cortex (p = 0.039) was reduced by 20% in hSOD1G93A mice. Also, the activities of the glycolytic enzyme pyruvate kinase were reduced in the cortex by 31% (p = 0.002), indicating alterations in glycolysis. No significant differences were seen in the total amounts as well as % 13C enrichments in most TCA cycle intermediates, suggesting largely normal TCA cycle function. On the other hand, oxoglutarate dehydrogenase activity was decreased in the cortex, which may indicate increased oxidative stress. Overall, this study revealed decreased activity of the PPP in the spinal cord and alterations in glycolysis in hSOD1G93A mouse CNS tissues at the early symptomatic stage of disease.

Entities:  

Keywords:  Energy metabolism; Glycolysis; Liquid chromatography-tandem mass spectrometry; Motor neuron disease; Pentose phosphate pathway; TCA cycle

Mesh:

Substances:

Year:  2019        PMID: 30685842     DOI: 10.1007/s12035-019-1485-6

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  50 in total

1.  Impaired oxidative metabolism in exercising muscle from ALS patients.

Authors:  G Siciliano; E Pastorini; L Pasquali; M L Manca; A Iudice; L Murri
Journal:  J Neurol Sci       Date:  2001-10-15       Impact factor: 3.181

2.  A comparison of cell and tissue extraction techniques using high-resolution 1H-NMR spectroscopy.

Authors:  J E Le Belle; N G Harris; S R Williams; K K Bhakoo
Journal:  NMR Biomed       Date:  2002-02       Impact factor: 4.044

3.  Analysis of the cytosolic proteome in a cell culture model of familial amyotrophic lateral sclerosis reveals alterations to the proteasome, antioxidant defenses, and nitric oxide synthetic pathways.

Authors:  Simon Allen; Paul Roy Heath; Janine Kirby; Stephen Barrie Wharton; Mark Robert Cookson; Fiona Mhairi Menzies; Rosamonde Elizabeth Banks; Pamela Jean Shaw
Journal:  J Biol Chem       Date:  2002-12-09       Impact factor: 5.157

4.  Factors correlated with hypermetabolism in patients with amyotrophic lateral sclerosis.

Authors:  J C Desport; P M Preux; L Magy; Y Boirie; J M Vallat; B Beaufrère; P Couratier
Journal:  Am J Clin Nutr       Date:  2001-09       Impact factor: 7.045

5.  Inhibition of Krebs cycle enzymes by hydrogen peroxide: A key role of [alpha]-ketoglutarate dehydrogenase in limiting NADH production under oxidative stress.

Authors:  L Tretter; V Adam-Vizi
Journal:  J Neurosci       Date:  2000-12-15       Impact factor: 6.167

6.  Mutant SOD1 alters the motor neuronal transcriptome: implications for familial ALS.

Authors:  Janine Kirby; Eugene Halligan; Melisa J Baptista; Simon Allen; Paul R Heath; Hazel Holden; Sian C Barber; Catherine A Loynes; Clare A Wood-Allum; Joseph Lunec; Pamela J Shaw
Journal:  Brain       Date:  2005-05-04       Impact factor: 13.501

7.  Evidence for defective energy homeostasis in amyotrophic lateral sclerosis: benefit of a high-energy diet in a transgenic mouse model.

Authors:  Luc Dupuis; Hugues Oudart; Frédérique René; Jose-Luis Gonzalez de Aguilar; Jean-Philippe Loeffler
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-19       Impact factor: 11.205

8.  Decreased glutamate transport by the brain and spinal cord in amyotrophic lateral sclerosis.

Authors:  J D Rothstein; L J Martin; R W Kuncl
Journal:  N Engl J Med       Date:  1992-05-28       Impact factor: 91.245

9.  Increased lipid peroxidation in sera of ALS patients: a potential biomarker of disease burden.

Authors:  E P Simpson; Y K Henry; J S Henkel; R G Smith; S H Appel
Journal:  Neurology       Date:  2004-05-25       Impact factor: 9.910

10.  Impaired oxidative metabolism and lipid peroxidation in exercising muscle from ALS patients.

Authors:  Gabriele Siciliano; Carla D'Avino; Alberto Del Corona; Renata Barsacchi; Claudia Kusmic; Anna Rocchi; Elena Pastorini; Luigi Murri
Journal:  Amyotroph Lateral Scler Other Motor Neuron Disord       Date:  2002-06
View more
  3 in total

Review 1.  Brain energy rescue: an emerging therapeutic concept for neurodegenerative disorders of ageing.

Authors:  Stephen C Cunnane; Mark J Millan; Eugenia Trushina; Cecilie Morland; Alessandro Prigione; Gemma Casadesus; Zane B Andrews; M Flint Beal; Linda H Bergersen; Roberta D Brinton; Suzanne de la Monte; Anne Eckert; Jenni Harvey; Ross Jeggo; Jack H Jhamandas; Oliver Kann; Clothide Mannoury la Cour; William F Martin; Gilles Mithieux; Paula I Moreira; Michael P Murphy; Klaus-Armin Nave; Tal Nuriel; Stéphane H R Oliet; Frédéric Saudou; Mark P Mattson; Russell H Swerdlow
Journal:  Nat Rev Drug Discov       Date:  2020-07-24       Impact factor: 84.694

Review 2.  CNS glucose metabolism in Amyotrophic Lateral Sclerosis: a therapeutic target?

Authors:  Tesfaye Wolde Tefera; Frederik J Steyn; Shyuan T Ngo; Karin Borges
Journal:  Cell Biosci       Date:  2021-01-11       Impact factor: 7.133

3.  Decreased Mitochondrial Function, Biogenesis, and Degradation in Peripheral Blood Mononuclear Cells from Amyotrophic Lateral Sclerosis Patients as a Potential Tool for Biomarker Research.

Authors:  Beatriz Grisolia Araujo; Luiz Felipe Souza E Silva; Jorge Luiz de Barros Torresi; Amanda Siena; Berenice Cataldo Oliveira Valerio; Mariana Dutra Brito; Tatiana Rosado Rosenstock
Journal:  Mol Neurobiol       Date:  2020-08-25       Impact factor: 5.590

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.